Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer

Bibliographic Details
Main Authors: Chiara Nicolazzo, Francesca Belardinilli, Salvatore Caponnetto, Angela Gradilone, Enrico Cortesi, Giuseppe Giannini, Paola Gazzaniga
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01414/full
_version_ 1823925467990720512
author Chiara Nicolazzo
Francesca Belardinilli
Salvatore Caponnetto
Angela Gradilone
Enrico Cortesi
Giuseppe Giannini
Giuseppe Giannini
Paola Gazzaniga
author_facet Chiara Nicolazzo
Francesca Belardinilli
Salvatore Caponnetto
Angela Gradilone
Enrico Cortesi
Giuseppe Giannini
Giuseppe Giannini
Paola Gazzaniga
author_sort Chiara Nicolazzo
collection DOAJ
first_indexed 2024-12-16T20:09:08Z
format Article
id doaj.art-fa6a122ffdbb4e5288ec66ede710eb1c
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-16T20:09:08Z
publishDate 2019-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-fa6a122ffdbb4e5288ec66ede710eb1c2022-12-21T22:18:12ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2019-12-01910.3389/fonc.2019.01414510181Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal CancerChiara Nicolazzo0Francesca Belardinilli1Salvatore Caponnetto2Angela Gradilone3Enrico Cortesi4Giuseppe Giannini5Giuseppe Giannini6Paola Gazzaniga7Liquid Biopsy Unit, Department of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, ItalyLiquid Biopsy Unit, Department of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyInstitute Pasteur-Cenci Bolognetti Foundation, Rome, ItalyLiquid Biopsy Unit, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italyhttps://www.frontiersin.org/article/10.3389/fonc.2019.01414/fullctDNARASEGFR inhibitiorsliquid biopsycolorectal cancer
spellingShingle Chiara Nicolazzo
Francesca Belardinilli
Salvatore Caponnetto
Angela Gradilone
Enrico Cortesi
Giuseppe Giannini
Giuseppe Giannini
Paola Gazzaniga
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
Frontiers in Oncology
ctDNA
RAS
EGFR inhibitiors
liquid biopsy
colorectal cancer
title Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
title_full Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
title_fullStr Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
title_full_unstemmed Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
title_short Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
title_sort why the therapeutic impact of ras mutation clearance in plasma ctdna deserves to be further explored in metastatic colorectal cancer
topic ctDNA
RAS
EGFR inhibitiors
liquid biopsy
colorectal cancer
url https://www.frontiersin.org/article/10.3389/fonc.2019.01414/full
work_keys_str_mv AT chiaranicolazzo whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer
AT francescabelardinilli whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer
AT salvatorecaponnetto whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer
AT angelagradilone whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer
AT enricocortesi whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer
AT giuseppegiannini whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer
AT giuseppegiannini whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer
AT paolagazzaniga whythetherapeuticimpactofrasmutationclearanceinplasmactdnadeservestobefurtherexploredinmetastaticcolorectalcancer